Basic & Clinical Medicine ›› 2024, Vol. 44 ›› Issue (8): 1080-1087.doi: 10.16352/j.issn.1001-6325.2024.08.1080

• Special Issues:Pulmonary Hypertension • Previous Articles     Next Articles

Inflammatory cells and vascular remodeling in pulmonary arterial hypertension

QIAN Xifeng1, HUA Lu1,2*   

  1. 1. Key Laboratory of Pulmonary Vascular Medicine, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037;
    2. Shenzhen Clinical Medical Research Center of Cardiovascular Diseases, Fuwai Shenzhen Hospital, Chinese Academy of Medical Sciences, Shenzhen 518057, China
  • Received:2024-06-06 Revised:2024-06-21 Online:2024-08-05 Published:2024-07-24
  • Contact: *ethannan@126.com

Abstract: Pulmonary arterial hypertension (PAH) is a severe and progressive pulmonary vascular disease mainly characterized by a continuous increase in pulmonary vascular resistance and rise of pulmonary artery pressure caused by pulmonary arteriolar lesions, ultimately resulting in right heart failure and even death. Pulmonary vascular remodeling is a characteristic pathological change of PAH, and its mechanism involves gene susceptibility, imbalance of vasoactive substances, abnormal energy metabolism and other potential factors. Recent studies have found that inflammatory reaction plays a crucial role in the mechanism of pulmonary vascular remodeling. Inflammatory cells are found to infiltrate and accumulate around the pulmonary vessels of PAH patients and of animal models. In addition, significantly high level of cytokines and auto-antibodies were also found in peripheral blood, which is closely related to poor prognosis of PAH. This article reviews the research progress about the potential role of inflammatory cells in the vascular remodeling of PAH and provides new ideas for developing of safe and effective treatment methods for PAH.

Key words: pulmonary arterial hypertension, pulmonary vascular remodeling, inflammation, inflammatory cells

CLC Number: